Efficacy of a password‐protected, pill‐dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery

Background Opioid misuse is a public health crisis, and unused postoperative opioids are an important source. Although 70% of pills prescribed go unused, only 9% are discarded. This study evaluated whether an inexpensive pill‐dispensing device with mail return capacity could enhance disposal of unused opioids after cancer surgery. Methods A prospective pilot study was conducted among adult patients who underwent major cancer‐related surgery. Patients received opioid prescriptions in a mechanical device (Addinex) linked to a smartphone application (app). The app provided passwords on a prescriber‐defined schedule. Patients could enter a password into the device and receive a pill if the prescribed time had elapsed. Patients were instructed to return the device and any unused pills in a disposal mailer. The primary end point was feasibility of device return, defined as ≥50% of patients returning the device within 6 weeks of surgery. Also explored was total pill use and return as well as patient satisfaction. Results Among 30 patients enrolled, the majority ( n = 24, 80%) returned the device, and 17 (57%) returned it within 6 weeks of surgery. In total, 567 opioid pills were prescribed and 170 (30%) were used. Of 397 excess pills, 332 (84% of unused pills, 59% of all pills prescribed) were disposed of by mail. Among 19 patients who obtained opioids from the device, most ( n = 14, 74%) felt the benefits of the device justified the added steps involved. Conclusions Use of an inexpensive pill‐dispensing device with mail return capacity is a feasible strategy to enhance disposal of unused postoperative opioids..

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:128

Enthalten in:

Cancer - 128(2022), 18, Seite 3392-3399

Beteiligte Personen:

Cogan, Jacob C. [VerfasserIn]
Accordino, Melissa K. [VerfasserIn]
Beauchemin, Melissa P. [VerfasserIn]
Spivack, John H. [VerfasserIn]
Ulene, Sophie R. [VerfasserIn]
Elkin, Elena B. [VerfasserIn]
Melamed, Alexander [VerfasserIn]
Taback, Bret [VerfasserIn]
Wright, Jason D. [VerfasserIn]
Hershman, Dawn L. [VerfasserIn]

BKL:

44.81

Anmerkungen:

© 2022 American Cancer Society

Umfang:

8

doi:

10.1002/cncr.34384

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WLY003741214